Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women

Human Immunology

Volumn 64, Issue 5, 2003, Pages 538-542

  Zehbe, Ingeborg ^a,b   Mytilineos, Joannis ^c   Wikström, Ingrid ^d   Henriksen, Rudi ^d   Edler, Lutz ^b   Tommasino, Massimo ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical cancer; E6 prototype; E6 variant; HLA; HPV16

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B44 ANTIGEN; HLA B51 ANTIGEN; HLA B57 ANTIGEN; UNCLASSIFIED DRUG;

ALLELISM; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HLA TYPING; HUMAN; IMMUNOGENETICS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

EID: 0037406240     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00033-8     Document Type: Article

References (15)

1. zur Hausen H: Viruses in human cancers. Science 254:1167, 1991.
2. Zehbe I, Wilander E, Delius H, Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829, 1998.
3. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M: Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441, 1998.
4. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler CM, Singer A: Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364, 1996.
5. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Gissmann L, Wilander E, Tommasino M: Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711, 2001.
6. Forssmann U, Mytilineos J, Scherer S, Opelz G: A method for HLA-DQA typing by the PCR-SSP technique. Transplant Int 7:515, 1999.
7. Mytilineos J, Lempert M, Scherer S, Schwarz V, Opelz G: Comparison of serological and DNA PCR-SSP typing results for HLA-A and HLA-B in 421 Black individuals. Hum Immunol 59:512, 1998.
8. Fleiss IL: Statistical Methods for Rates and Proportions. New York: Wiley, 1973.
9. Rammensee H-G, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenet 50:213, 1999 (access via: http://www.uni-ruebingen.de/uni/kxi/).
10. Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, Meijer CJ, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JM: HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78:166, 1998.
11. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Barrholomew JS, Young LS, et al: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464, 1995.
12. Etherington IJ, Ellis JR, Luesley DM, Moffitt DD, Young LS: Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72:56, 1999.
13. Luxton J, Mant C, Greenwood B, Derias N, Nath R, Shepherd P, Cason J: HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia. J Med Virol 60:337, 2000.
14. Lu J, Celis E: Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Cancer Res 60:5223, 2000.
15. Zhan QJ, Chen SS, Saari CA, Massuci MG, Tufaro F, Jefferies WA: Evidence of selective processing of immunodominant epitopes in virally infected cells. J Immunol 164:4513, 2000.